ExpressCells—A Rapidly-Growing Genetic Engineering Company – CEO/CFO Magazine

— ExpressCells. Cell line gene editing; Cell line development; CRISPR DNA editing, CRISPR gene editing technology; Knock-in; Cell line service.

CEO Matt Handel interviewed by CEO/CFO Magazine about the company’s growth, its first US Patent and plans for future expansion

ExpressCells leverages proprietary gene-editing tools to customize human cell lines for drug discovery, toxicology, and other biologic research.